Differential Expression of S100C in Thyroid Lesions

International Journal of Surgical Pathology

Volumn 12, Issue 2, 2004, Pages 107-115

  Torres Cabala, Carlos ^a   Panizo Santos, Angel ^a   Krutzsch, Henry C ^a   Barazi, Heba ^a   Namba, Masayoshi ^b   Sakaguchi, Masakiyo ^b   Roberts, David D ^a   Merino, Maria J ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b OKAYAMA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Calgizzarin; Galectin 3; Immunohistochemistry; Proteomics; S100C; Thyroid

Indexed keywords

CALCIUM BINDING PROTEIN; GALECTIN 3; PROTEIN S 100; PROTEIN S100C; UNCLASSIFIED DRUG;

ARTICLE; CELL NUCLEUS; CONTROLLED STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MICRODISSECTION; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEOMICS; THYROID ADENOMA; THYROID CANCER; THYROID DISEASE; THYROID FOLLICULAR CARCINOMA; THYROID HYPERPLASIA; THYROID NODULE; THYROID PAPILLARY CARCINOMA; TWO DIMENSIONAL GEL ELECTROPHORESIS; VALIDATION PROCESS;

ADENOCARCINOMA, FOLLICULAR; ADENOMA; CARCINOMA, PAPILLARY; CELL TRANSFORMATION, NEOPLASTIC; CHROMATOGRAPHY, LIQUID; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GALECTIN 3; HUMANS; HYPERPLASIA; IMMUNOENZYME TECHNIQUES; MASS SPECTROMETRY; S100 PROTEINS; THYROID GLAND; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 2142717373     PISSN: 10668969     EISSN: None     Source Type: Journal    
DOI: 10.1177/106689690401200203     Document Type: Article

References (39)

1. Rosai J, Carcangiu ML, De Lellis RA. Tumors of the thyroid gland. In Rosai J, Sobin LH (eds): Atlas of tumor pathology, third series, fascicle 5. Armed Forces Institute of Pathology, Washington, DC, pp. 49-62, 1992
2. LiVolsi VA. Follicular lesions of the thyroid. In Zorab R (ed): Surgical pathology of the thyroid. WB Saunders, Philadelphia, pp. 173-212, 1990
3. Gasbarri A, Martegani MP, Del Prete F, Lucante T, Natali PG, Bartolazzi A. Galectin-3 and CD44v6 isoforms in the preoperative evaluation of thyroid nodules. J Clin Oncol 17:3494-3502, 1999
4. Coli A, Bigotti G, Zucchetti F, Negro F, Massi G. Galectin-3, a marker of well-differentiated thyroid carcinoma, is expressed in thyroid nodules with cytological atypia. Histopathology 40:80-87, 2002
5. Pandey A, Mann M. Proteomics to study genes and genomes. Nature 40:837-846, 2000
6. Wulfkuhle JD, Sgroi DC, Krutzsch H, McLean K, McGarvey K, Knowlton M, Chen S, Shu H, Sahin A, Kurek R, Wallwiener D, Merino MJ, Petricoin EF, Zhao Y, Steeg PS. Proteomics of human breast ductal carcinoma in situ. Cancer Res 62:6740-6749, 2002
7. Brown JM, Krutzsch H, Shu H, Zhao Y, Liotta LA. Kohn EC, Petricoin EF. Proteomic analysis and identification of new biomarkers and therapeutic targets for invasive ovarian cancer. Proteomics 2:76-84, 2002
8. Merino MJ, Roberts DD, Bryant B, Krutzch HC, Al-Barazi H, Libutti SK, Sarlis NJ, Panizo A. Differences of protein expression in benign and malignant microdissected thyroid tissues. Abstract. 2002 Annual Meeting. United States and Canadian Academy of Pathology. Lab Invest 82:117A, 2002
9. 2+-binding properties of calgizzarin (S100C) isolated from chicken gizzard smooth muscle. Biochem Cell Biol 74:687-694, 1996
10. Watanabe MY, Ando H, Todoroki H, Minami H, Hidaka H. Molecular cloning and sequencing of a cDNA clone encoding a new calcium binding protein, named calgizzarin, from rabbit lung. Biochem Biophys Res Commun 63:259-267, 1991
11. 2+-binding protein from smooth muscle and non-muscle tissues. J Biol Chem 266:18668-18673, 1991
12. Naka M, Qing ZX, Sasaki T, Kise H, Tawara I, Hamaguchi S, Tanaka T. Purification and characterization of a novel calcium-binding protein, S100C, from porcine heart. Biochim Biophys Acta 1223:348-353, 1994
13. Ohta H, Sasaki T, Naka M, Hiraoka O, Miyamoto C, Furuichi Y, Tanaka T. Molecular cloning and expression of the cDNA coding for a new member of the S100 protein family from porcine cardiac muscle. FEBS Lett 295:93-96, 1991
14. Sakaguchi M, Miyazaki M, Inoue Y, Tsuji T, Kouchi H, Tanaka T, Yamada H, Namba M. Relationship between contact inhibition and intranuclear S100C of normal human fibroblasts. J Cell Biol 149:1193-1206, 2000
15. Sakaguchi M, Yamada H, Tsuji T, Inoue Y, Miyazaki M, Tanaka T, Namba M. Loss of nuclear localization of the S100C protein in immortalized human fibroblasts. Radiat Res 155:208-214, 2001
16. Sakaguchi M, Miyazaki M, Kondo T, Namba M. Upregulation of S100C in normal human fibroblasts in the process of aging in vitro. Exp Gerontol 36:1317-1325, 2001
17. Kondo A, Sakaguchi M, Makino E, Namba M, Okada S, Huh N. Localization of S100C immunoreactivity in various human tissues. Acta Med Okayama 56:31-34, 2002
18. Ilg EC, Schäfer BW, Heizmann CW. Expression pattern of S100 calcium-binding proteins in human tumors. Int J Cancer 68:325-332, 1996
19. Tanaka M, Adzuma K, Iwami M, Yoshimoto K, Monden Y, Itakura M. Human calgizzarin; one colorectal cancer-related gene selected by a large scale random cDNA sequencing and Northern blot analysis. Cancer Lett 89:195-200, 1995
20. Van Ginkel PR, Gee RL, Walker TM, Hu D, Heizmann CW, Polans AS. The identification and differential expression of calcium-binding proteins associated with ocular melanoma. Biochim Biophys Acta 1448:290-297, 1998
21. Lloyd RV. Distinguishing benign from malignant thyroid lesions: Galectin 3 as the latest candidate. Endocr Pathol 12:255-257, 2001
22. Bartolazzi A, Gasbarri A, Papotti M, Bussolati G, Lucante T, Khan A, Inohara H, Marandino F, Orlandi F, Nardi F, Vecchione A, Tecce R, Larsson O, and the Thyroid Cancer Study Group. Application of an immunodiagnostic method for improving preoperative diagnosis of nodular thyroid lesions. Lancet 357:1644-1650, 2001
23. Xu XC, El-Naggar AK, Lotan R. Differential expression of galectin-1 and galectin-3 in thyroid tumors. Am J Pathol 147:815-822, 1995
24. Liotta LA, Kohn EC, Petricoin EF. Clinical proteomics. Personalized molecular medicine. JAMA 286:2211-2214, 2001
25. Inada H, Naka M, Tanaka T, Davey GE, Heizmann C. Human S100A11 exhibits differential steady-state RNA levels in various tissues and a distinct subcellular localization. Biochem Biophys Res Commun 263:135-138, 1999
26. Cvejic D, Savin S, Paunovic I, Tatic S, Havelka M, Sinadinovic J. Immunohistochemical localization of galectin-3 in malignant and benign human thyroid tissue. Anticancer Res 18:2637-2642, 1998
27. Martins L, Matsuo SE, Ebina KN, Kulcsar MAV, Friguglietti CUM, Kimura ET. Galectin-3 messenger ribonucleic acid and protein are expressed in benign thyroid tumors. J Clin Endocrinol Metab 87:4806-4810, 2002
28. Orlandi F, Saggiorato E, Pivano G, Puligheddu B, Termine A, Cappia S, De Giuli P, Angeli A. Galectin-3 is a presurgical marker of human thyroid carcinoma. Cancer Res 58:3015-3020, 1998
29. Nascimento MC, Bisi H, Alves VA, Longatto-Filho A, Kanamura CT, Medeiros-Neto G. Differential reactivity for galectin-3 in Hürthle cell adenomas and carcinomas. Endocr Pathol 12:275-279, 2001
30. Inohara H, Honjo Y, Tadashi Y, Akahani S, Yoshida J, Hattori K, Okamoto S, Swada T, Raz A, Kubo T. Expression of galectin-3 in fine-needle aspirates as a diagnostic marker differentiating benign from malignant thyroid neoplasms. Cancer 85:2475-2484, 1999
31. Nikiforova MN, Lynch RA, Biddinger PW, Alexander EK, Dorn GW, Tallini G, Kroll TG, Nikiforov YE. RAS point mutations and PAX8-PPARγ rearrangement in thyroid tumors: Evidence for distinct molecular pathways in thyroid follicular carcinoma. J Clin Endocrinol Metab 88:2318-2326, 2003
32. Bernet VJ, Anderson J, Vaishnav Y, Solomon B, Adair CE, Saji M, Burman KD, Burch HB, Ringel MD. Determination of galectin-3 messenger ribonucleic acid overexpression in papillary thyroid cancer by quantitative reverse transcription-polymerase chain reaction. J Clin Encocrinol Metab 87:4792-4796, 2002
33. Saggiorato E, Cappia S, De Giuli P, Mussa A, Pancani G, Caraci P, Angeli A, Orlandi F. Galectin-3 as a presurgical immunocytodiagnostic marker of minimally invasive follicular thyroid carcinoma. J Clin Endocrinol Metab 86:5152-5158, 2001
34. Fernández PL, Merino MJ, Gómez M, Campo E, Medina T, Castronovo V, Sanjuán X, Cardesa A, Liu F, Sobel ME. Galectin-3 and laminin expression in neoplastic and non-neoplastic thyroid tissue. J Pathol 181:80-86, 1997
35. Kawachi K, Matsushita Y, Yonezawa S, Nakano S, Shirao K, Natsugoe S, Sueyoshi K, Aikou T, Sato E. Galectin-3 expression in various thyroid neoplasms and its possible role in metastasis formation. Hum Pathol 31:428-433, 2000
36. Papotti M, Volante M, Saggiorato E, Deandreis D, Veltri A, Orlandi F. Role of galectin-3 immunodetection in the cytological diagnosis of thyroid cystic papillary carcinoma. Eur J Endocrinol 147:515-521, 2002
37. Van den Brûle FA, Waltregny D, Liu F, Castronovo V. Alteration of the cytoplasmic/nuclear expression pattern of galectin-3 correlates with prostate carcinoma progression. Int J Cancer (Pred Oncol) 89:361-367, 2000
38. Sanjuán X, Fernández PL, Castells A, Castronovo V, van der Brûle FA, Liu F, Cardesa A, Campo E. Differential expression of galectin-3 and galectin-1 in colorectal cancer progression. Gastroenterology 113:1906-1915, 1997
39. Honjo Y, Inohara H, Akahani S, Yoshii T, Takenaka Y, Yoshida J, Hattori K, Tomiyama Y, Raz A, Kubo T. Expression of cytoplasmic galectin-3 as a prognostic marker in tongue carcinoma. Clin Cancer Res 6:4635-4640, 2000